The German Nobel laureate Otto Warburg, one of twentieth century's leading scientists observed that tumour cells exhibit an increased aerobic glucose metabolism in their glycolysis process.
Seeing that, Warburg concluded that cancer should be interpreted as a mitochondrial dysfunction, but his hypothesis was not accepted at the time, and was forgotten by the scientific community until it was recently experimentally confirmed, arousing great interest in biotechnological and pharmaceutical companies.
The comeback of Warburg's hypothesis has been greatly helped by the research of a group of Spanish physicians and scientists from the “12 de octubre” hospital in Madrid (López-Ríos, García-García, Pozo-Rodriguez, López-Encuentra and Ballestín) and from the “Universidad Autónoma de Madrid” (Sanchéz-Aragó, Ortega y Berrendero) under the direction of José Manuel Cuezva, professor of biochemistry and molecular biology at the “Centro de Biología Molecular Severo Ochoa”.
Their latest research work, recently published in the prestigious journal Cancer Research, describes how the activity or expression of the protein beta-F1-ATPase (responsible for the synthesis of ATP) that controls the aerobic usage of glucose in a cell, shows an inverse correlation between the glycolysis process and the metabolic energy supply of mitochondria.
The study carried out by Dr. Cuezva´s team focused on lung cancer patients. The increase in glucose capture by the tumours was measured using Positron emission tomography (PET), and then contrasted with the expression of protein beta-F1-ATPase, determined from the tumours obtained after surgery, finding an inverse correlation between the two variables.
They also describe in their research work, that when the beta-F1-ATPase protein expression is inhibited or its activity reduced in the carcinomas, the tumour cells are forced to increase their intake of glucose by glycolytic means. Although this research trend is not new, since this same team already has reported in earlier work how the disruption of the mitochondrial bioenergetic function is a metabolic signature of tumours, and how this could be used in clinical prognosis of patients with colorectal, lung or breast cancer. Among other applications that the team and other research groups consider promising are the uses of this signature as a tool to predict the reaction of a patient to a treatment, or as a therapeutic target against cancer.
The commercial applications of such prospective therapies are already protected by a patent that is owned by the “Universidad Autónoma de Madrid” and is licensed to the Spanish biotechnology firm “Fina Biotech, S.L”. Therefore this study might not sound like a new scientific discovery, but it provides the first evidence that integrates molecular and functional data supporting Warburg's hypothesis emphasizing the importance of the mitochondria in human pathology and more specifically in cancer biology.
Oficina de Cultura Científica | alfa
Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH
Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences